Equities Analysts Issue Forecasts for PTGX Q2 Earnings
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) – Research analysts at Wedbush boosted their Q2 2025 earnings per share estimates for shares of Protagonist Therapeutics in a research note issued on Wednesday, May 7th. Wedbush analyst Y. Zhong now forecasts that the company will post earnings of ($0.59) per share for the quarter, up from […]
Protagonist Therapeutics, Inc. (NASDAQ:PTGX – Free Report) – Research analysts at Wedbush boosted their Q2 2025 earnings per share estimates for shares of Protagonist Therapeutics in a research note issued on Wednesday, May 7th. Wedbush analyst Y. Zhong now forecasts that the company will post earnings of ($0.59) per share for the quarter, up from […]
